Skip to main navigation Skip to search Skip to main content

A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/12 → 10/31/22

Funding

  • Children's Hospital of Philadelphia: $31,500.00